Goldfracht, Idit http://orcid.org/0000-0002-2575-2159
Protze, Stephanie
Shiti, Assad
Setter, Noga http://orcid.org/0000-0002-1407-9210
Gruber, Amit
Shaheen, Naim
Nartiss, Yulia
Keller, Gordon
Gepstein, Lior
Article History
Received: 10 September 2018
Accepted: 1 December 2019
First Online: 7 January 2020
Competing interests
: G.K. is a scientific cofounder and advisor of BlueRock Therapeutics. S.P. has an active consulting agreement with BlueRock Therapeutics. The remaining authors declare no competing interests.